Dimethyl fumarate-associated PML

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-015-0553-6
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [21] Patient coaching to optimize management of delayed-release dimethyl fumarate-associated gastrointestinal events and flushing: five years of experience
    Niemczyk, G.
    Begus-Nahrmann, Y.
    Rolfes, S.
    Rosenstroem, H.
    Grundler, M. -T.
    Maeurer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 612 - 612
  • [23] NONFATAL PML IN A PATIENT WITH MULTIPLE SCLEROSIS TREATED WITH DIMETHYL FUMARATE
    Baharnoori, Moogeh
    Lyons, Jennifer
    Dastagir, Akram
    Koralnik, Igor
    Stankiewicz, James M.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (05):
  • [24] PML with dimethyl fumarate-No convincing case against natalizumab
    Diebold, Martin
    Altersberger, Valerian
    Decard, Bernhard F.
    Kappos, Ludwig
    Derfuss, Tobias
    Lorscheider, Johannes
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (12) : 1687 - 1688
  • [25] PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
    van Oosten, Bob W.
    Killestein, Joep
    Barkhof, Frederik
    Polman, Chris H.
    Wattjes, Mike P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17): : 1658 - 1659
  • [26] PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate
    Nieuwkamp, Dennis J.
    Murk, Jean-Luc
    van Oosten, Bob W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (15): : 1474 - 1476
  • [27] Fatal PML in a patient treated with compounded dimethyl fumarate with only modest lymphocytopenia
    Murk, J. L.
    Nieuwkamp, D. J.
    Van Hecke, W.
    Frijlink, D. W.
    Killestein, J.
    Wattjes, M. P.
    Van Oosten, B. W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E6 - E6
  • [28] Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury
    Samuels, Ryan
    Bayerri, Carla Roca
    Sayer, John A.
    Price, D. Ashley
    Payne, Brendan A. I.
    AIDS, 2017, 31 (09) : 1297 - 1301
  • [29] Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-release Dimethyl Fumarate
    Rose, John
    Alvarez, Enrique
    Okuda, Darin
    Gudesblatt, Mark
    Riser, Emily
    Spelman, Timothy
    Fam, Sami
    Riester, Katherine
    Wu, Fan
    Miller, Catherine
    Butzkueven, Helmut
    NEUROLOGY, 2019, 92 (15)
  • [30] PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?
    Lehmann-Horn, Klaus
    Penkert, Horst
    Grein, Peter
    Leppmeier, Ulrich
    Teuber-Hanselmann, Sarah
    Hemmer, Bernhard
    Berthele, Achim
    NEUROLOGY, 2016, 87 (04) : 440 - 441